Stocktoria
CROSS COUNTRY HEALTHCARE INC CCRN
CROSS COUNTRY HEALTHCARE INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $2.0B | $2.8B | $1.7B | $836.4M | $822.2M | $816.5M | $865.0M | $833.5M |
| SG&A expense | $200.7M | $233.4M | $300.3M | $324.2M | $216.4M | $173.8M | $182.0M | $180.2M | $187.4M | $179.8M |
| Operating income | -$84.4M | -$16.9M | $112.7M | $269.9M | $139.3M | -$9.2M | -$15.7M | -$12.9M | $11.7M | $6.2M |
| Interest expense | — | — | $8.1M | $14.4M | $6.9M | $2.9M | $5.3M | $5.7M | $4.2M | $6.1M |
| Income tax | $11.3M | -$1.8M | $30.3M | $67.1M | $1.2M | -$188,000 | $31.7M | -$2.5M | -$34.5M | -$4.2M |
| Net income | -$94.9M | -$14.6M | $72.6M | $186.0M | $132.0M | -$13.0M | -$57.7M | -$17.0M | $37.5M | $8.0M |
| EPS (diluted) | $-2.93 | $-0.44 | $2.05 | $4.95 | $3.53 | $-0.36 | $-1.61 | $-0.48 | $1.01 | $0.15 |
| Operating cash flow | $48.3M | $120.1M | $248.5M | $134.1M | -$85.6M | $27.2M | $5.5M | $21.0M | $45.5M | $30.1M |
| Free cash flow | $40.1M | $111.4M | $234.5M | $125.3M | -$92.8M | $22.6M | $2.6M | $16.4M | $40.4M | $23.6M |
| Cash & equivalents | $108.7M | $81.6M | $17.1M | $3.6M | $1.0M | $1.6M | $1.0M | $16.0M | $25.5M | $20.6M |
| Total assets | $449.0M | $589.3M | $681.1M | $949.6M | $732.8M | $357.0M | $382.4M | $427.0M | $467.7M | $388.4M |
| Total liabilities | $126.1M | $170.3M | $213.4M | $498.1M | $435.3M | $202.1M | $218.9M | $208.8M | $230.0M | $236.6M |
| Shareholders' equity | $322.8M | $419.0M | $473.4M | $457.2M | $297.5M | $154.9M | $163.5M | $218.2M | $237.7M | $151.8M |
Growth · year-over-year · Revenue CAGR 2.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -21.6% | -33.5% | -28.0% | +67.2% | +100.5% | +1.7% | +0.7% | -5.6% | +3.8% | — |
| Net income growth | — | -120.0% | -60.9% | +40.9% | — | — | — | -145.2% | +370.9% | +80.3% |
| EPS growth | — | -121.5% | -58.6% | +40.2% | — | — | — | -147.5% | +573.3% | +7.1% |
| Free cash flow growth | -64.0% | -52.5% | +87.2% | — | -510.8% | +768.1% | -84.1% | -59.4% | +71.0% | +48.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.